• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在马拉维,nephrin 作为镰状细胞肾小球病的生物标志物。

Nephrin as a biomarker of sickle cell glomerulopathy in Malawi.

机构信息

UNC Project-Malawi, Lilongwe, Malawi.

Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee.

出版信息

Pediatr Blood Cancer. 2018 Jun;65(6):e26993. doi: 10.1002/pbc.26993. Epub 2018 Feb 7.

DOI:10.1002/pbc.26993
PMID:29411937
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5911184/
Abstract

BACKGROUND

Glomerulopathy is an increasingly identified complication in young patients with sickle cell disease (SCD). Hyperfiltration and albuminuria followed by declining glomerular filtration rates and eventual end-stage renal disease (ESRD) is assumed to be the typical progression of glomerular disease. There are only a few reported biomarkers to identify early-stage renal disease in SCD.

PROCEDURES

We detail the renal profile of 101 children with SCD in Malawi and propose a novel urinary biomarker for the identification of early renal disease.

RESULTS

Among children with sickle cell anemia, 24.8% had a urine albumin-creatinine ratio of 30 mg/g or above. In univariate analysis, only patients with higher urinary nephrin, a urinary marker of glomerular injury, had significantly greater odds of having albuminuria. In multivariable analysis, nephrin remained significantly associated with albuminuria. A nephrin-creatinine ratio (NCR) cut-point of 622 ng/mg, the 50 percentile, was associated with a 45.8 times greater odds of having albuminuria in children with nephrinuria above this value. Further analysis revealed this urinary NCR cut-point to have 96% sensitivity, 64% specificity, 47% positive predictive value, and 98% negative predictive value for the presence of albuminuria.

CONCLUSIONS

These data suggest that a substantial number of children with SCD in Malawi have renal disease and could be at risk for worsening nephropathy and ESRD as they age. Our data suggest that urinary nephrin could be utilized as an early marker of glomerular disease in SCD.

摘要

背景

肾小球病是镰状细胞病(SCD)年轻患者日益确定的并发症。肾小球疾病的典型进展被认为是高滤过和白蛋白尿,随后肾小球滤过率下降,最终导致终末期肾病(ESRD)。目前只有少数报道的生物标志物可用于识别 SCD 中的早期肾病。

方法

我们详细介绍了马拉维 101 名 SCD 儿童的肾脏情况,并提出了一种新的尿生物标志物来识别早期肾脏疾病。

结果

在镰状细胞贫血患儿中,24.8%的患儿尿白蛋白/肌酐比值为 30mg/g 或以上。在单变量分析中,只有尿足细胞标志物——尿神经纤毛蛋白较高的患者发生白蛋白尿的几率显著更高。在多变量分析中,神经纤毛蛋白与白蛋白尿仍显著相关。神经纤毛蛋白/肌酐比值(NCR)切点为 622ng/mg(第 50 百分位数),高于该值的患儿发生白蛋白尿的几率增加 45.8 倍。进一步分析显示,该尿 NCR 切点对白蛋白尿的检出具有 96%的灵敏度、64%的特异性、47%的阳性预测值和 98%的阴性预测值。

结论

这些数据表明,马拉维相当一部分 SCD 儿童患有肾脏疾病,随着年龄的增长,他们可能有发生进行性肾病和 ESRD 的风险。我们的数据表明,尿神经纤毛蛋白可用作 SCD 中肾小球疾病的早期标志物。

相似文献

1
Nephrin as a biomarker of sickle cell glomerulopathy in Malawi.在马拉维,nephrin 作为镰状细胞肾小球病的生物标志物。
Pediatr Blood Cancer. 2018 Jun;65(6):e26993. doi: 10.1002/pbc.26993. Epub 2018 Feb 7.
2
Urinary Transforming Growth Factor β-1 as a Marker of Renal Dysfunction in Sickle Cell Disease.尿转化生长因子β-1作为镰状细胞病肾功能不全的标志物
Pediatr Neonatol. 2016 Jun;57(3):174-80. doi: 10.1016/j.pedneo.2015.05.001. Epub 2015 Oct 24.
3
Novel kidney injury biomarkers in a large cohort of children with sickle cell anemia.一大群镰状细胞贫血儿童中的新型肾损伤生物标志物
Biomark Med. 2021 Aug;15(12):999-1009. doi: 10.2217/bmm-2020-0769. Epub 2021 Jul 22.
4
Renal function in adult Jamaicans with homozygous sickle cell disease.成年牙买加纯合子镰状细胞病患者的肾功能
Hematology. 2015 Aug;20(7):422-8. doi: 10.1179/1607845414Y.0000000213. Epub 2014 Nov 28.
5
Chronic kidney disease and albuminuria in children with sickle cell disease.儿童镰状细胞病的慢性肾脏病和白蛋白尿。
Clin J Am Soc Nephrol. 2011 Nov;6(11):2628-33. doi: 10.2215/CJN.01600211. Epub 2011 Sep 22.
6
Kidney biopsy findings in children with sickle cell disease: a Midwest Pediatric Nephrology Consortium study.镰状细胞病患儿的肾脏活检结果:中西部儿科肾脏病联盟的研究。
Pediatr Nephrol. 2019 Aug;34(8):1435-1445. doi: 10.1007/s00467-019-04237-3. Epub 2019 Apr 3.
7
Nephrinuria associates with multiple renal traits in type 2 diabetes.尿肾蛋白与 2 型糖尿病的多种肾脏特征相关。
Nephrol Dial Transplant. 2011 Aug;26(8):2508-14. doi: 10.1093/ndt/gfq738. Epub 2010 Dec 31.
8
Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease.尿转化生长因子-β1 作为镰状细胞病肾功能障碍的标志物。
Pediatr Nephrol. 2011 Feb;26(2):275-80. doi: 10.1007/s00467-010-1677-9. Epub 2010 Nov 25.
9
Glomerular hyperfiltration and albuminuria in children with sickle cell anemia.镰状细胞贫血患儿的肾小球高滤过和白蛋白尿。
Pediatr Nephrol. 2011 Aug;26(8):1285-90. doi: 10.1007/s00467-011-1857-2. Epub 2011 May 11.
10
Novel marker for the detection of sickle cell nephropathy: soluble FMS-like tyrosine kinase-1 (sFLT-1).用于检测镰状细胞肾病的新型标志物:可溶性FMS样酪氨酸激酶-1(sFLT-1)。
Pediatr Nephrol. 2015 Dec;30(12):2163-8. doi: 10.1007/s00467-015-3172-9. Epub 2015 Aug 4.

引用本文的文献

1
Nontargeted Plasma Proteomic Analysis of Renal Disease and Pulmonary Hypertension in Patients with Sickle Cell Disease.镰状细胞病患者肾脏疾病和肺动脉高压的非靶向血浆蛋白质组分析。
J Proteome Res. 2024 Mar 1;23(3):1039-1048. doi: 10.1021/acs.jproteome.3c00748. Epub 2024 Feb 14.
2
Urinary nephrin-a potential marker of early glomerular injury: a systematic review and meta-analysis.尿足细胞裂孔隔膜蛋白-早期肾小球损伤的潜在标志物:系统评价和荟萃分析。
J Nephrol. 2024 Jan;37(1):39-51. doi: 10.1007/s40620-023-01585-0. Epub 2023 Feb 20.
3
The nephropathy of sickle cell trait and sickle cell disease.镰状细胞性状和镰状细胞病的肾病
Nat Rev Nephrol. 2022 Jun;18(6):361-377. doi: 10.1038/s41581-022-00540-9. Epub 2022 Feb 21.
4
Sickle cell nephropathy: A review of novel biomarkers and their potential roles in early detection of renal involvement.镰状细胞肾病:新型生物标志物及其在肾脏受累早期检测中的潜在作用综述
World J Clin Pediatr. 2022 Jan 9;11(1):14-26. doi: 10.5409/wjcp.v11.i1.14.
5
Progression of albuminuria in patients with sickle cell anemia: a multicenter, longitudinal study.镰状细胞贫血患者白蛋白尿的进展:一项多中心、纵向研究。
Blood Adv. 2020 Apr 14;4(7):1501-1511. doi: 10.1182/bloodadvances.2019001378.
6
Hyperfiltration predicts long-term renal outcomes in humanized sickle cell mice.高滤过预测人源化镰状细胞小鼠的长期肾脏结局。
Blood Adv. 2019 May 14;3(9):1460-1475. doi: 10.1182/bloodadvances.2018028878.
7
Effect of renin-angiotensin-aldosterone system blocking agents on progression of glomerulopathy in sickle cell disease.血管紧张素-肾素-醛固酮系统阻断剂对镰状细胞病肾小球病进展的影响。
Br J Haematol. 2019 Jan;184(2):246-252. doi: 10.1111/bjh.15651. Epub 2018 Nov 21.

本文引用的文献

1
Losartan for the nephropathy of sickle cell anemia: A phase-2, multicenter trial.氯沙坦治疗镰状细胞贫血肾病:一项2期多中心试验。
Am J Hematol. 2017 Sep;92(9):E520-E528. doi: 10.1002/ajh.24810. Epub 2017 Jul 19.
2
Clinical and genetic predictors of renal dysfunctions in sickle cell anaemia in Cameroon.喀麦隆镰状细胞贫血患者肾功能障碍的临床和遗传预测因素
Br J Haematol. 2017 Aug;178(4):629-639. doi: 10.1111/bjh.14724. Epub 2017 May 3.
3
Thrombin-Induced Podocyte Injury Is Protease-Activated Receptor Dependent.凝血酶诱导的足细胞损伤是蛋白酶激活受体依赖性的。
J Am Soc Nephrol. 2017 Sep;28(9):2618-2630. doi: 10.1681/ASN.2016070789. Epub 2017 Apr 19.
4
Albuminuria Is Associated with Endothelial Dysfunction and Elevated Plasma Endothelin-1 in Sickle Cell Anemia.蛋白尿与镰状细胞贫血中的内皮功能障碍及血浆内皮素-1升高有关。
PLoS One. 2016 Sep 26;11(9):e0162652. doi: 10.1371/journal.pone.0162652. eCollection 2016.
5
Early renal damage in patients with sickle cell disease in sub-Saharan Africa: a multinational, prospective, cross-sectional study.撒哈拉以南非洲镰状细胞病患者的早期肾脏损害:一项多国前瞻性横断面研究。
Lancet Haematol. 2014 Nov;1(2):e64-73. doi: 10.1016/S2352-3026(14)00007-6. Epub 2014 Oct 28.
6
Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.镰状细胞病的凝血异常:与临床结局的关系及疾病修饰疗法的影响。
Blood Rev. 2016 Jul;30(4):245-56. doi: 10.1016/j.blre.2015.12.003. Epub 2015 Dec 24.
7
Kidney Disease among Patients with Sickle Cell Disease, Hemoglobin SS and SC.镰状细胞病、血红蛋白SS型和SC型患者中的肾脏疾病
Clin J Am Soc Nephrol. 2016 Feb 5;11(2):207-15. doi: 10.2215/CJN.03940415. Epub 2015 Dec 15.
8
Six Months of Hydroxyurea Reduces Albuminuria in Patients with Sickle Cell Disease.六个月的羟基脲可降低镰状细胞病患者的蛋白尿水平。
J Am Soc Nephrol. 2016 Jun;27(6):1847-53. doi: 10.1681/ASN.2014111126. Epub 2015 Nov 19.
9
Endothelin-1 contributes to the progression of renal injury in sickle cell disease via reactive oxygen species.内皮素-1通过活性氧促进镰状细胞病肾损伤的进展。
Br J Pharmacol. 2016 Jan;173(2):386-95. doi: 10.1111/bph.13380.
10
Establishing sickle cell diagnostics and characterizing a paediatric sickle cell disease cohort in Malawi.在马拉维建立镰状细胞诊断方法并对儿童镰状细胞病队列进行特征分析。
Br J Haematol. 2016 Jul;174(2):325-9. doi: 10.1111/bjh.13769. Epub 2015 Oct 12.